Hydrogel Microtumor Arrays to Evaluate Nanotherapeutics

Area of Science:

• Biomedical Engineering
• Cancer Research
• Nanomedicine

Background:

• Nanoparticle drug formulations offer advantages in cancer therapy, including improved targeting and reduced toxicity.
• Current preclinical models often fail to accurately predict nanomedicine efficacy in humans.

Purpose of the Study:

• To develop a novel microtumor array platform for evaluating nanomedicine.
• To investigate the relationship between cancer cell states and nanoparticle uptake.
• To assess the potential of nanoparticle drug formulations in targeting cancer stem cells.

Main Methods:

• Hydrogel micropatterning was used to create a microtumor array.
• The array allowed for the partitioning and simultaneous testing of heterogeneous cancer cell populations.
• Deformation cytometry was employed to analyze cell membrane mechanics.

Main Results:

• A direct relationship was discovered between the fraction of stem-like cells and nanoparticle uptake.
• Cancer stem-like cells demonstrated more mechanically deformable cell membranes.
• The microtumor array platform provided high reproducibility in drug uptake and efficacy assessments.

Conclusions:

• Nanoparticle drug formulations are effective in targeting cancer stem cells, which are implicated in drug resistance and metastasis.
• The developed microtumor array is a valuable tool for preclinical nanomedicine evaluation.
• This approach enhances the potential of nanomedicine for overcoming therapeutic challenges in cancer treatment.